  See all
 |
Articles: Research & Development |
Prior Articles
Sanofi-aventis and U.S. Biotechnology company Merrimack enter into an Exclusive Global Collaboration and Licensing Agreement for a monoclonal antibody in Oncology
Sanofi-aventis, 10/02/09
Free full text
Bristol-Myers Squibb and ZymoGenetics to Present Final Phase Ib Data on PEG-Interferon Lambda at AASLD 2009
Bristol Myers-Squibb Company, 10/02/09
Free full text
Establishment of the Chugai Academy for Advanced Oncology - Elevating Japan's cancer treatment to a global level
Chugai Pharmaceutical Co., 10/02/09
Free full text
Changes on HL7s Board
HealthDataManagement, 10/02/09 Two-year Phase III study shows Novartis oral MS therapy FTY720 significantly reduces relapses and disability progression
Novartis, 10/01/09
Free full text
Two new meta-analyses confirm once-daily Lantus efficacy and reduced risk of hypoglycaemia compared to NPH Insulin
Sanofi-aventis, 10/01/09
Free full text
RoACTEMRA filed in Europe for the Inhibition of Joint Damage and Improvement in Physical Function in Rheumatoid Arthritis
Chugai Pharmaceutical Co., 10/01/09
Free full text
InfoLogix Receives NASDAQ Warning
HealthDataManagement, 10/01/09 House Democratic leaders hear hospitals message on reform
American Hospital Association News, 10/01/09
Free full text
Dell to Buy Perot Systems
HealthDataManagement, 10/01/09 Sanofi-aventis launches major insulin research program in partnership with the international scientific community
Sanofi-aventis, 09/30/09
Free full text
Weighing EHR/PHR Links
HealthDataManagement, 09/30/09 Nabi Biopharmaceuticals Receives Grant Supporting Further NicVAX Development
Nabi Biopharmaceuticals, 09/30/09
Free full text
GSK provides update on regulatory filings for Zunrisa/Rezonic
GlaxoSmithKline, 09/29/09
Free full text
Ohio Hospital Outsources I.T.
HealthDataManagement, 09/29/09 MediGene Sharpens Focus through In-House Reorganization
MediGene, 09/29/09
Free full text
Fallon Clinic Offers EHR Tips
HealthDataManagement, 09/29/09 Novartis A(H1N1) Pandemic Influenza vaccine Focetria receives positive opinion from CHMP
Novartis, 09/28/09
Free full text
Merck Statement About JANUVIA™ (sitagliptin) and JANUMET™
Merck & Co., 09/28/09
Free full text
Genmab announces positive top-line results for arzerra™ in front line nhl
Genmab, 09/28/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
